ClinicalTrials.gg
RecruitingNCT05269368MECH-ORLUpdated Jul 6, 2022

Interest of Wicking for Ossicular Surgery and Myringoplasty

An interventional study of Wicking and No wicking in Post-Op Complication and Otologic Disease, sponsored by University Hospital, Tours. Recruiting at 6 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-06.

Sponsored by University Hospital, Tours · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started May 2022; still recruiting 4 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Myringoplasties and ossicular surgery are very common procedures. Following these otological surgeries, most surgeons install a wicking. This intervention consists of placing a wick, absorbable or not, in the external acoustic meatus, after having replaced the tympanomeatal flap.

Read the detailed description

Myringoplasties and ossicular surgery are very common procedures. Following these otological surgeries, most surgeons install a wicking. This intervention consists of placing a wick, absorbable or not, in the external acoustic meatus, after having replaced the tympanomeatal flap.

Putting in place a wicking often requires to remove this wicking, feared by the patient. In addition, wicking leads to obstruction of the external acoustic meatus responsible for functional discomfort (feeling of fullness in the ear, pain, significant conductive deafness) which can last from one to several weeks depending on the type of wicking.

Despite these drawbacks, the rationale for wicking has never been established, the choice of wick type is often empirical, and its necessity is sometimes controversial in the literature. Recent studies have studied the absence of wicking as an alternative to overcome its many drawbacks. No prospective, randomized, multicenter study has been performed to show the superiority of wicking in healing following middle ear surgery (myringoplasty, stapedo-vestibular ankylosis, ossiculoplasty) via the duct or the endaural route. The only study with a high level of evidence concerns only endoscopic surgery. This study has the advantage of showing that with comparable audiometric and healing results, the absence of wicking allows a reduced operating time, an earlier reduction in otorrhea and the feeling of blocked ears, and an earlier improvement of hearing. Given this work in the literature, our hypothesis is that tympanic healing is not impaired in the absence of wicking.

02

Conditions studied

  • Post-Op Complication
  • Otologic Disease

Keywords

  • Ossicular surgery
  • Otological surgeries
  • Wicking
03

In context

Postoperative Complications

1,332 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.

This study's planned enrollment of 150 is above the median of 114 across 766 interventional studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

University Hospital, Tours is the lead sponsor of 307 studies on the registry; 79 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient (age 18 = or + ), whose mother tongue is French or who understands French language
  • Ossicular surgery (fitting of a partial or total ossicular prosthesis) or myringoplasty performed endoscopically, from the speculum, from the duct or from the endaural.
  • Tympanic reconstruction by all types of grafts: cartilage, fascia, autologous fat
  • Written consent signed by the participant
  • Affiliation to a social security scheme,

Exclusion criteria

Exclusion Criteria:

  • Pregnant or breastfeeding woman, patient under legal protection, guardianship or curatorship.
  • Need for a retroauricular approach.
  • Need for annulus detachment> 60%
  • Presence of cholesteatoma or middle ear tumor
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    No wicking

    Absence of Wicking after intervention

    Procedure: No wicking

  • Active comparator
    Control

    Wicking after intervention

    Procedure: Wicking

Interventions

  • ProcedureWicking

    Absorbable or non-absorbable wicking

  • ProcedureNo wicking

    No wicking after surgery

06

What researchers measure

Primary outcomes

  1. Tympanic and external auditory canal healing

    Healing of tympanic membrane and external auditory canal, evaluated blindly by 3 experts, on an oto-endoscopy picture.

    Time frame: Three months after intervention.

Secondary outcomes

  1. Audiometric results

    Audiometric results defined by the pure-tone average on 500, 1000, 2000 and 3000 Hz frequencies.

    Time frame: Pre-operative, 3 months, 12 months

  2. Post-operative satisfaction

    Visual Analogic scale (0-10 (min-max))

    Time frame: Immediate post-operative, day 7-10, day 30, 3 months

  3. Post-operative pain

    Visual Analogic scale (0-10 (min-max))

    Time frame: Immediate post operative,day 7-10, day 30, 3 months

  4. Post-operative quality of life

    Glasgow Benefit Inventory (-100 (min) to +100 (max))

    Time frame: Day 7-10, day 30, 3 months,12 months

  5. Post-operative stress

    Perceived Stress Scale (PSS-10) 10-50 (min-max) Never to often

    Time frame: Pre-operative, day 7-10, day 30, 3 months, 12 months

  6. Operative time

    Operative time of the otology surgery, in minutes

    Time frame: 30-120 minutes

  7. Complications

    Questionnaire given to surgeons, allowing description of complications

    Time frame: At any time of the follow-up,up to 1 year

07

Study locations

5 of 6 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05269368
Responsible party
Sponsor
First posted
Mar 8, 2022
Start date
May 16, 2022
Primary completion
May 16, 2025 (estimated)
Completion
May 16, 2026 (estimated)
Last update
Jul 6, 2022

Study contacts

Charles AUSSEDAT, MD
Contact
c.aussedat@chu-tours.fr
+33247474747 ext. 74518
Wiebe de JONG, MSc
Contact
w.dejong@chu-tours.fr
+33247474680
Charles AUSSEDAT, MD
study director · University Hospital of TOURS

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion